About Galena Biopharma, Inc.

Website
Website
Employees
Employees
1-10 employees View all
Industry
Industry
Biotechnology
Location
Location
San Ramon CA United States
Description
Information
Galena Biopharma, Inc. (NASDAQ: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care. Galena’s development portfolio ranges from mid- to late-stage clinical assets, including a robust immunotherapy program led by NeuVax™ (nelipepimut-S) currently in an international, Phase 3 clinical trial. The Company’s commercial drugs include Abstral® (fentanyl) Sublingual Tablets and Zuplenz® (ondansetron) Oral Soluble Film. Collectively, Galena’s clinical and commercial strategy focuses on identifying and advancing therapeutic opportunities to improve cancer care, from direct treatment of the disease to the reduction of its debilitating side-effects. For more information please visit us at www.galenabiopharma.com.

Galena Biopharma, Inc. Alternatives

Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology

Frequently Asked Questions about Galena Biopharma, Inc.

What is Galena Biopharma, Inc. email format?

The widely used Galena Biopharma, Inc. email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.


What is Galena Biopharma, Inc. customer service number?

To contact Galena Biopharma, Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more